These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9222362)

  • 1. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
    Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
    J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus.
    Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
    J Virol; 1995 Jan; 69(1):308-19. PubMed ID: 7983723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons.
    Contag CH; Plagemann PG
    J Virol; 1989 Oct; 63(10):4362-9. PubMed ID: 2550670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
    Chen Z; Li K; Rowland RR; Plagemann PG
    J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus.
    Harty JT; Plagemann PG
    J Virol; 1990 Dec; 64(12):6257-62. PubMed ID: 2243393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase-elevating virus correlates with increased expression of endogenous retrovirus in motor neurons.
    Contag CH; Plagemann PG
    Microb Pathog; 1988 Oct; 5(4):287-96. PubMed ID: 3237056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of virus-induced age-dependent poliomyelitis by interferon-gamma.
    Cafruny WA; Haven TR; Lawson SR; Wong GH; Rowland RR
    Antiviral Res; 1997 Sep; 36(1):1-9. PubMed ID: 9330756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
    Harty JT; Chan SP; Contag CH; Plagemann PG
    J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.
    Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():581-92. PubMed ID: 7897349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro.
    Inada T; Yamazaki S
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2437-44. PubMed ID: 1655956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
    Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
    J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.
    Chen Z; Li K; Rowland RR; Anderson GW; Plagemann PG
    J Neurovirol; 1998 Oct; 4(5):560-8. PubMed ID: 9839654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between presence of lactate dehydrogenase-elevating virus RNA and antigens in motor neurons and paralysis in infected C58 mice.
    Contag CH; Chan SP; Wietgrefe SW; Plagemann PG
    Virus Res; 1986 Dec; 6(3):195-209. PubMed ID: 3554816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of lactate dehydrogenase-elevating virus in various species cell lines infected with dual-, ampho- and xenotropic murine leukaemia viruses in vitro.
    Inada T
    Virus Res; 1993 Mar; 27(3):267-81. PubMed ID: 8387719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the ability of lactate dehydrogenase-elevating virus and its virion RNA to infect murine leukemia virus-infected or -uninfected cell lines.
    Inada T; Kikuchi H; Yamazaki S
    J Virol; 1993 Sep; 67(9):5698-703. PubMed ID: 8394468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
    Plagemann PG; Chen Z; Li K
    Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.